Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia

Gerhard Zugmaier,Max S. Topp,Shilpa Alekar,Andreas Viardot,Heinz-August Horst,Svenja Neumann,Matthias Stelljes,Ralf C. Bargou,Goebeler M,Dorothea Wessiepe,Evelyn Degenhard,Nicola Gökbuget,Matthias Klinger

Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia

2014

Gerhard Zugmaier
Max S. Topp
Shilpa Alekar
Andreas Viardot
Heinz-August Horst
Svenja Neumann
Matthias Stelljes
Ralf C. Bargou
Goebeler M
Dorothea Wessiepe
Evelyn Degenhard
Nicola Gökbuget
Matthias Klinger

Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia

Keywords:

Immunology
Minimal residual disease
Cancer research
Immunoglobulin levels
Antibody
Blinatumomab
Lymphoblastic Leukemia
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Medicine
follow up studies
long term follow up

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations